Insights

Strategic Focus Targeting neuropsychiatric disorders with patented ketamine analogs positions Amorsa as a specialized partner for pharma companies seeking novel fast-acting therapies for treatment-resistant depression, PTSD, and OCD, suggesting collaboration opportunities in research licenses, co-development, or exclusive rights.

Selective Partnerships Historical disclosures show engagement with major industry players like Janssen, indicating openness to research, option, and license agreements; sales reps should pursue partnership discussions for preclinical to early clinical-stage assets or collaborative programs.

Leader Network Board-level additions from the medical and pharmaceutical community imply credibility and potential executive-level introductions; leverage these connections for high-touch business development, advisory roles, or strategic alliances.

Financial Signals Reported revenue in the low tens of millions alongside a lean employee base suggests a startup-like and collaboration-driven model; position offerings around enablement services, partnering for later-stage funding, or joint development funding scenarios.

Market Positioning Pursuit of novel small molecules in neuropsychiatry complements the broader ketamine-analogue landscape; identify potential synergies with contract research, manufacturing, and commercialization partners to accelerate clinical milestones and market access.

Similar companies to Amorsa Therapeutics, Inc.

Amorsa Therapeutics, Inc. Tech Stack

Amorsa Therapeutics, Inc. uses 8 technology products and services including WordPress, Google Fonts API, jQuery Migrate, and more. Explore Amorsa Therapeutics, Inc.'s tech stack below.

  • Content Management System
  • Google Fonts API
    Font Scripts
  • jQuery Migrate
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • Lua
    Programming Languages
  • Yoast SEO
    Search Engines
  • Nginx
    Web Servers

Amorsa Therapeutics, Inc.'s Email Address Formats

Amorsa Therapeutics, Inc. uses at least 1 email format:
Amorsa Therapeutics, Inc. Email FormatsExamplePercentage
FLast@amorsatx.comJDoe@amorsatx.com
100%

Frequently Asked Questions

What is Amorsa Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Amorsa Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Amorsa Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Amorsa Therapeutics, Inc.'s official website is amorsatx.com and has social profiles on LinkedIn.

How much revenue does Amorsa Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, Amorsa Therapeutics, Inc.'s annual revenue is estimated to be $1M - $10M.

What is Amorsa Therapeutics, Inc.'s NAICS code?

Minus sign iconPlus sign icon
Amorsa Therapeutics, Inc.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Amorsa Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, Amorsa Therapeutics, Inc. has approximately 1 employees across 3 continents, including North America, Africa and Asia. Key team members include President & Chief Executive Officer: J. B. Explore Amorsa Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Amorsa Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Amorsa Therapeutics, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Amorsa Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Amorsa Therapeutics, Inc.'s tech stack includes WordPress, Google Fonts API, jQuery Migrate, Modernizr, Underscore.js, Lua, Yoast SEO and Nginx.

What is Amorsa Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Amorsa Therapeutics, Inc.'s email format typically follows the pattern of FLast@amorsatx.com. Find more Amorsa Therapeutics, Inc. email formats with LeadIQ.

When was Amorsa Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Amorsa Therapeutics, Inc. was founded in 2013.
Amorsa Therapeutics, Inc. logo

Amorsa Therapeutics, Inc.

Pharmaceutical ManufacturingMassachusetts, United States0-1 Employees

Amorsa Therapeutics, Inc. is a Southborough, Massachusetts-based company in the pharmaceutical manufacturing space focused on developing novel, patented ketamine analogs for neuropsychiatric disorders. Its work targets treatment-resistant depression, PTSD, and obsessive-compulsive disorder, with the goal of expanding options where current therapies may be insufficient. The organization advances small molecule candidates derived from its ketamine-analog technology. 

In May 2018, Amorsa appointed Jeffrey Wiesen to its Board of Directors. Previously, the company pursued a research, option and license agreement with Janssen Pharmaceuticals to develop and commercialize a novel ketamine-analog drug candidate for treatment-resistant depression.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2013
Employees
0-1

Section iconFunding & Financials

  • $1M - $10M

    Amorsa Therapeutics, Inc.'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.